<?xml version='1.0' encoding='utf-8'?>
<document id="23523942"><sentence text="Stilbene glucoside inhibits the glucuronidation of emodin in rats through the down-regulation of UDP-glucuronosyltransferases 1A8: application to a drug-drug interaction study in Radix Polygoni Multiflori."><entity charOffset="0-18" id="DDI-PubMed.23523942.s1.e0" text="Stilbene glucoside" /><entity charOffset="51-57" id="DDI-PubMed.23523942.s1.e1" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s1.e0" e2="DDI-PubMed.23523942.s1.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s1.e0" e2="DDI-PubMed.23523942.s1.e1" /></sentence><sentence text="The integrated effects of herbal medicines were the outcome of all of the inherent components" /><sentence text=" Currently, few studies have focused on the multicomponent interactions in an herbal medicine to elucidate its pharmacological and/or toxicological effects" /><sentence text=" In this study, an attempt was made to investigate the interaction between stilbene glucosides and the anthraquinones contained in Radix Polygoni Multiflori (RPM) and to explore the interaction's mechanism from the perspective of UDP-glucuronosyltransferase (UGT) regulation"><entity charOffset="75-94" id="DDI-PubMed.23523942.s4.e0" text="stilbene glucosides" /><entity charOffset="103-117" id="DDI-PubMed.23523942.s4.e1" text="anthraquinones" /><pair ddi="false" e1="DDI-PubMed.23523942.s4.e0" e2="DDI-PubMed.23523942.s4.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s4.e0" e2="DDI-PubMed.23523942.s4.e1" /></sentence><sentence text="" /><sentence text="The extract of RPM was separated into a stilbene glucoside fraction and a emodin fraction"><entity charOffset="40-58" id="DDI-PubMed.23523942.s6.e0" text="stilbene glucoside" /><entity charOffset="74-80" id="DDI-PubMed.23523942.s6.e1" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s6.e0" e2="DDI-PubMed.23523942.s6.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s6.e0" e2="DDI-PubMed.23523942.s6.e1" /></sentence><sentence text=" A rapid high-performance liquid chromatography-mass spectrometry method was developed and validated to disclose the influence of stilbene glucoside on the pharmacokinetics of emodin in rats"><entity charOffset="130-148" id="DDI-PubMed.23523942.s7.e0" text="stilbene glucoside" /><entity charOffset="176-182" id="DDI-PubMed.23523942.s7.e1" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s7.e0" e2="DDI-PubMed.23523942.s7.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s7.e0" e2="DDI-PubMed.23523942.s7.e1" /></sentence><sentence text=" Drug and Statistics 2" /><sentence text="0 was used for the estimation of the pharmacokinetic parameters" /><sentence text=" Gene expression analysis in liver and intestinal tissues was performed by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) method" /><sentence text="" /><sentence text="The analytical method appeared to be suitable for the analysis of emodin with desirable linearity, accuracy, precision and stability, and the total analysis time was less than 2 min on a short column"><entity charOffset="66-72" id="DDI-PubMed.23523942.s12.e0" text="emodin" /></sentence><sentence text=" Glucuronide of emodin, which is the major metabolite of emodin, was determined after Î²-glucuronidase hydrolysis"><entity charOffset="1-12" id="DDI-PubMed.23523942.s13.e0" text="Glucuronide" /><entity charOffset="16-22" id="DDI-PubMed.23523942.s13.e1" text="emodin" /><entity charOffset="57-63" id="DDI-PubMed.23523942.s13.e2" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s13.e0" e2="DDI-PubMed.23523942.s13.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s13.e0" e2="DDI-PubMed.23523942.s13.e1" /><pair ddi="false" e1="DDI-PubMed.23523942.s13.e0" e2="DDI-PubMed.23523942.s13.e2" /><pair ddi="false" e1="DDI-PubMed.23523942.s13.e1" e2="DDI-PubMed.23523942.s13.e1" /><pair ddi="false" e1="DDI-PubMed.23523942.s13.e1" e2="DDI-PubMed.23523942.s13.e2" /></sentence><sentence text=" As the in vivo pharmacokinetic studies had indicated, the AUC, Cmax and T1/2 of emodin were increased after the stilbene glucoside treatment, and the glucuronidation of emodin was significantly inhibited"><entity charOffset="81-87" id="DDI-PubMed.23523942.s14.e0" text="emodin" /><entity charOffset="113-131" id="DDI-PubMed.23523942.s14.e1" text="stilbene glucoside" /><entity charOffset="170-176" id="DDI-PubMed.23523942.s14.e2" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s14.e0" e2="DDI-PubMed.23523942.s14.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s14.e0" e2="DDI-PubMed.23523942.s14.e1" /><pair ddi="false" e1="DDI-PubMed.23523942.s14.e0" e2="DDI-PubMed.23523942.s14.e2" /><pair ddi="false" e1="DDI-PubMed.23523942.s14.e1" e2="DDI-PubMed.23523942.s14.e1" /><pair ddi="false" e1="DDI-PubMed.23523942.s14.e1" e2="DDI-PubMed.23523942.s14.e2" /></sentence><sentence text=" The mRNA levels from UGT1A8 and UGT1A2 were decreased by stilbene glucoside treatment"><entity charOffset="58-76" id="DDI-PubMed.23523942.s15.e0" text="stilbene glucoside" /></sentence><sentence text=" In contrast, the expression of UGT1A1, UGT1A6 and UGT1A9 mRNA was increased in the liver following treatment" /><sentence text="" /><sentence text="The influence of stilbene glucoside on the pharmacokinetics of emodin may be attributed to the inhibition of UGT1A8 mRNA expression"><entity charOffset="17-35" id="DDI-PubMed.23523942.s18.e0" text="stilbene glucoside" /><entity charOffset="63-69" id="DDI-PubMed.23523942.s18.e1" text="emodin" /><pair ddi="false" e1="DDI-PubMed.23523942.s18.e0" e2="DDI-PubMed.23523942.s18.e0" /><pair ddi="false" e1="DDI-PubMed.23523942.s18.e0" e2="DDI-PubMed.23523942.s18.e1" /></sentence><sentence text=" Thus, it is important to extend this research to deepen our understanding of the pharmacological and/or toxicological effects of RPM" /><sentence text="" /></document>